Terms: = Liver cancer AND MSI2, ENSG00000153944, 124540
10 results:
1. Prognostic role and biologic features of Musashi-2 expression in colon polyps and during colorectal cancer progression.
Kharin L; Bychkov I; Karnaukhov N; Voloshin M; Fazliyeva R; Deneka A; Frantsiyants E; Kit O; Golemis E; Boumber Y
PLoS One; 2021; 16(7):e0252132. PubMed ID: 34237057
[TBL] [Abstract] [Full Text] [Related]
2. Myofibroblast-Specific msi2 Knockout Inhibits HCC Progression in a Mouse Model.
Qu C; He L; Yao N; Li J; Jiang Y; Li B; Peng S; Hu K; Chen D; Chen G; Huang W; Cao M; Fan J; Yuan Y; Ye W; Hong J
Hepatology; 2021 Jul; 74(1):458-473. PubMed ID: 33609283
[TBL] [Abstract] [Full Text] [Related]
3. Musashi2 promotes the progression of pancreatic cancer through a novel ISYNA1-p21/ZEB-1 pathway.
Zhou L; Sheng W; Jia C; Shi X; Cao R; Wang G; Lin Y; Zhu F; Dong Q; Dong M
J Cell Mol Med; 2020 Sep; 24(18):10560-10572. PubMed ID: 32779876
[TBL] [Abstract] [Full Text] [Related]
4. Musashi2 contributes to the maintenance of CD44v6+ liver cancer stem cells via notch1 signaling pathway.
Wang X; Wang R; Bai S; Xiong S; Li Y; Liu M; Zhao Z; Wang Y; Zhao Y; Chen W; Billiar TR; Cheng B
J Exp Clin Cancer Res; 2019 Dec; 38(1):505. PubMed ID: 31888685
[TBL] [Abstract] [Full Text] [Related]
5. Musashi 2 contributes to the stemness and chemoresistance of liver cancer stem cells via LIN28A activation.
Fang T; Lv H; Wu F; Wang C; Li T; Lv G; Tang L; Guo L; Tang S; Cao D; Wu M; Yang W; Wang H
Cancer Lett; 2017 Jan; 384():50-59. PubMed ID: 27721018
[TBL] [Abstract] [Full Text] [Related]
6. The Novel KLF4/msi2 Signaling Pathway Regulates Growth and Metastasis of Pancreatic cancer.
Guo K; Cui J; Quan M; Xie D; Jia Z; Wei D; Wang L; Gao Y; Ma Q; Xie K
Clin Cancer Res; 2017 Feb; 23(3):687-696. PubMed ID: 27449499
[TBL] [Abstract] [Full Text] [Related]
7. Musashi2 as a novel predictive biomarker for liver metastasis and poor prognosis in colorectal cancer.
Zong Z; Zhou T; Rao L; Jiang Z; Li Y; Hou Z; Yang B; Han F; Chen S
Cancer Med; 2016 Apr; 5(4):623-30. PubMed ID: 26775684
[TBL] [Abstract] [Full Text] [Related]
8. The Msi Family of RNA-Binding Proteins Function Redundantly as Intestinal Oncoproteins.
Li N; Yousefi M; Nakauka-Ddamba A; Li F; Vandivier L; Parada K; Woo DH; Wang S; Naqvi AS; Rao S; Tobias J; Cedeno RJ; Minuesa G; Y K; Barlowe TS; Valvezan A; Shankar S; Deering RP; Klein PS; Jensen ST; Kharas MG; Gregory BD; Yu Z; Lengner CJ
Cell Rep; 2015 Dec; 13(11):2440-2455. PubMed ID: 26673327
[TBL] [Abstract] [Full Text] [Related]
9. Transformation of the intestinal epithelium by the msi2 RNA-binding protein.
Wang S; Li N; Yousefi M; Nakauka-Ddamba A; Li F; Parada K; Rao S; Minuesa G; Katz Y; Gregory BD; Kharas MG; Yu Z; Lengner CJ
Nat Commun; 2015 Mar; 6():6517. PubMed ID: 25774828
[TBL] [Abstract] [Full Text] [Related]
10. Musashi2 predicts poor prognosis and invasion in hepatocellular carcinoma by driving epithelial-mesenchymal transition.
He L; Zhou X; Qu C; Hu L; Tang Y; Zhang Q; Liang M; Hong J
J Cell Mol Med; 2014 Jan; 18(1):49-58. PubMed ID: 24305552
[TBL] [Abstract] [Full Text] [Related]
